RETRACTED: Ginsenoside Rg1 protects human retinal pigment epithelial ARPE-19 cells from toxicity of high glucose by up-regulation of miR-26a

Life Sci. 2019 Mar 15:221:152-158. doi: 10.1016/j.lfs.2019.02.021. Epub 2019 Feb 11.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments of Dr Elisabeth Bik regarding this article “… the Western blot bands in all 400+ papers are all very regularly spaced and have a smooth appearance in the shape of a dumbbell or tadpole, without any of the usual smudges or stains. All bands are placed on similar looking backgrounds, suggesting they were copy/pasted from other sources, or computer generated”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.

Keywords: Diabetic retinopathy; ERK/Wnt/β-catenin; Ginsenoside Rg1; High glucose; microRNA-26a.

Publication types

  • Retracted Publication

MeSH terms

  • Apoptosis
  • Apoptosis Regulatory Proteins
  • Cell Line
  • Cell Survival
  • Ginsenosides / metabolism*
  • Ginsenosides / pharmacology*
  • Glucose / adverse effects
  • Glucose / metabolism
  • Humans
  • MAP Kinase Signaling System / drug effects
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Oxidative Stress
  • Reactive Oxygen Species
  • Retinal Pigment Epithelium / drug effects
  • Retinal Pigments / genetics
  • Signal Transduction
  • Transcriptional Activation
  • Up-Regulation
  • Wnt Signaling Pathway / drug effects

Substances

  • Apoptosis Regulatory Proteins
  • Ginsenosides
  • MIRN26A microRNA, human
  • MicroRNAs
  • Reactive Oxygen Species
  • Retinal Pigments
  • Glucose
  • ginsenoside Rg1